| 利妥昔单抗治疗风湿性疾病的研究进展 |
| |
| 引用本文： | 王逸申,汪年松. 利妥昔单抗治疗风湿性疾病的研究进展[J]. 世界临床药物, 2012, 33(2): 70-73,77 |
| |
| 作者姓名： | 王逸申 汪年松 |
| |
| 作者单位： | 1.上海交通大学附属第六人民医院肾脏风湿科,上海,200233;2.上海交通大学附属第六人民医院肾脏风湿科,上海,200233 |
| |
| 摘 要： | 利妥昔单抗作为一种靶向治疗的免疫抑制药物,最初用于淋巴瘤的治疗,近年其用于风湿性疾病治疗也引起关注.本文综述利妥昔单抗治疗风湿性疾病的临床应用.
|
| 关 键 词： | 利妥昔单抗 自身免疫性疾病 风湿性疾病 |
Advances in the treatment of rheumatic diseases with rituximab |
| |
| WANG Yi-shen,WANG Nian-song. Advances in the treatment of rheumatic diseases with rituximab[J]. WORLD CLINICAL DRUGS, 2012, 33(2): 70-73,77 |
| |
| Authors: | WANG Yi-shen WANG Nian-song |
| |
| Affiliation: | (Departmemt of Nephrology and Rheumatology,Shanghai No.6 People’s Hospital,Shanghai Jiaotong University,Shanghai 200233,China) |
| |
| Abstract: | As a targeted immunosuppressive drug,rituximab is commonly used in the treatment of lymphoma.Recently,its efficacy in the treatment of rheumatic diseases has been concerned.This article reviews the clinical application in rheumatic diseases. |
| |
| Keywords: | rituximab autoimmune disease rheumatic disease |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
